Norman Brito-Dellan, M.D.
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Hospital Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Program Director, Onco-Hospitalist Fellowship Program, Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Professor, Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 1994 | Central University of Venezuela, "Luis Razetti" School of Medicine, Caracas, VE, MD |
Postgraduate Training
| 2024-2024 | R25 Knowledge Synthesis Workshop: Systematic Reviews, Meta-Analyses, and Clinical Decision Making, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2023-2023 | Office of Online Learning, External Education. Certificate of Achievement, HMX Pro Immunology- Novel Therapies for Chronic Inflammation, Harvard Medical School, Houston, Texas |
| 2022-2022 | Office of Online Learning, External Education. Certificate of Achievement, HMX Pro Immunology- Immuno-oncology, Harvard Medical School, Cambridge, Massachusetts |
| 2020-2021 | Health Educators Fellowship Program, The University of Texas Health Science Center at Houston (UTHealth), Houston, Texas |
| 2010-2012 | Clinical Safety and Effectiveness Program, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2001-2002 | Hematology/Oncology- Palliative Medicine Fellowship Program, Hospice and Palliative Medicine, Cleveland Clinic Foundation, Cleveland, Ohio |
| 1998-2001 | Categorical Internal Medicine Residency Program, Internal Medicine, University of Utah, Salt Lake City, Utah |
Licenses & Certifications
| 2025 | DEA |
| 2024 | BLS |
| 2024 | ACLS |
| 2011 | Texas Medical License |
| 2010 | American Board of Hospice and Palliative Medicine |
| 2001 | American Board of Internal Medicine |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2019
Administrative Appointments/Responsibilities
Program Director, Oncologic Hospitalist Fellowship Program, Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - Present
Program Director, Oncologic Hospitalist Fellowship Program, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2020
Medical Director, Palliative Care Program, Dixie Regional Medical Center, St. George, UT, 2010 - 2011
Medical Director, Intermountain Home Care and Hospice, St. George, UT, 2007 - 2011
Medical Director, Zion's Way Hospice, St. George, UT, 2005 - 2006
Medical Director, Odyssey Hospice, St. George, UT, 2005 - 2006
Medical Director, Southwest Utah Community Health Center, St. George, UT, 2003 - 2006
Medical Director, Southwest Utah Public Health Department, St. George, UT, 2003 - 2006
Other Professional Positions
Hospitalist, Hospitalist, Dixie Regional Medical Center, Saint George, Utah, 2007 - 2011
Medical Director, Internal Medicine, Southwest Utah Community Health Center, Saint George, Utah, 2003 - 2006
Intramural Institutional Committee Activities
RME credit earned: 1 credit, Acute Hospital Management of Hypercalcemia Institutional Algorithm, The University of Texas MD Anderson Cancer Center, 2024
Extramural Institutional Committee Activities
Member, Acute Cancer Care Center (ACC)/Inpatient (IP) Integrated Care Pathway for the Initial Diagnosis and Management of Suspected Immune-Checkpoint Inhibitor (ICI)-Related Adverse Events (irAEs), The University of Texas MD Anderson Cancer Center, 2022
Member, DoIM Education Task Force, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, DoIM Toxicity Working Group, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Transition to Hospice Working Group, The University of Texas MD Anderson Cancer Center, 2019 - Present
Graduate Medical Education (GME) Curriculum Subcommittee, Graduate Medical Education Committee (GMEC), The University of Texas MD Anderson Cancer Center, 2017 - Present
Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2016 - 2021
Member, PRS Retirement Board, The University of Texas MD Anderson Cancer Center, 2015 - 2019
Member, CME Advisory Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2019
Honors & Awards
| 2025 | Nominated, 2025 Division of Internal Medicine Employee & Faculty Excellence Awards in Education, The University of Texas MD Anderson Cancer Center Division of Internal Medicine |
| 2024 | Nominated, 2024 Division of Internal Medicine Employee & Faculty Excellence Awards in Education, The University of Texas MD Anderson Cancer Center Division of Internal Medicine |
| 2024 | Nominated, Employee & Faculty Excellence Awards in Education, Division of Internal Medicine |
| 2022 - 2024 | Co-Chair, Hemostasis Study Group, Multinational Association for Supportive Care in Cancer (MASCC) |
| 2022 - 2024 | Vice-Chair, MASCC Hemostasis Study Group, Winner of the 2022 Outstanding Study Group Award |
| 2021 - 2024 | Multi-Year Appointment Award |
| 2015 | MASCC Fatigue Study Group Outstanding Junior Investigator Research Award, MASCC |
| 2012 | Celebrating Improvement at MD Anderson Recognition for Act Project, "Standardizing Insulin Management in the Hospitalized Cancer Patient" |
| 2010 | Glycemic Control Mentored Implementation 2010/2011 Program, Society of Hospital Medicine |
| 1993 | VIII International Scientific Congress of FELSOCEM, Quito, Ecuador |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2024. Updates in Hospital Medicine. General Internal Medicine Clinical and Research Conference. Conference. Updates in Hospital Medicine. General Internal Medicine Clinical and Research Conference. Houston, TX, US.
- 2024. Emergent Management of Common Oncologic Emergencies. Graduate Medical Education (GME) Curriculum Subcommittee. Conference. Emergent Management of Common Oncologic Emergencies. Graduate Medical Education (GME) Curriculum Subcommittee. Houston, TX, US.
- 2023. Cytokine-release syndrome (CRS) after using an anti-PD-L1 and radiotherapy in a patient with cholangiocarcinoma: An unusual presentation at the Onco-Hospitalist Teaching Service. FY23 IOTOX Educational Lecture Series. Conference. Cytokine-release syndrome (CRS) after using an anti-PD-L1 and radiotherapy in a patient with cholangiocarcinoma: An unusual presentation at the Onco-Hospitalist Teaching Service. FY23 IOTOX Educational Lecture Series. Houston, TX, US.
- 2022. Diagnosis and Management of Immune Checkpoint Inhibitor (ICI)-Related Pneumonitis on the Hospitalist Service: Department of Hospital Medicine (DHM) iTox QI Project 2.0. Department of Hospital Medicine,. Conference. Diagnosis and Management of Immune Checkpoint Inhibitor (ICI)-Related Pneumonitis on the Hospitalist Service: Department of Hospital Medicine (DHM) iTox QI Project 2.0. Department of Hospital Medicine,. Houston, TX, US.
- 2022. Care pathway for the inpatient management of immune checkpoint inhibitor-related adverse events. MD Anderson Immuno-Oncologic Toxicity Initiative Lecture Series. Conference. Care pathway for the inpatient management of immune checkpoint inhibitor-related adverse events. MD Anderson Immuno-Oncologic Toxicity Initiative Lecture Series. Houston, TX, US.
- 2022. Care Pathway for the Inpatient Management of Immune Checkpoint Inhibitor-Related Adverse Events. Conference. Care Pathway for the Inpatient Management of Immune Checkpoint Inhibitor-Related Adverse Events. Houston, TX, US.
- 2021. Palliative Care in Onco-Hospital Medicine (virtual on-demand). Conference. Palliative Care in Onco-Hospital Medicine (virtual on-demand). Houston, TX, US.
- 2021. Education at the Department of Hospital Medicine. Conference. Education at the Department of Hospital Medicine. Houston, TX, US.
- 2021. Managing Immune Checkpoint Inhibitor(ICI)-Related Pneumonitis on the Hospitalist Service: iTox QI Project Roll-Out. Conference. Managing Immune Checkpoint Inhibitor(ICI)-Related Pneumonitis on the Hospitalist Service: iTox QI Project Roll-Out. HOUSTON, TX, US.
- 2019. Management of Patients With Fever and Neutropenia Through The Arc of Time. A Narrative Review. Conference. Management of Patients With Fever and Neutropenia Through The Arc of Time. A Narrative Review. Houston, TX, US.
- 2017. Treatment Trends and Outcomes in Healthcare-Associated Pneumonia. Conference. Treatment Trends and Outcomes in Healthcare-Associated Pneumonia. Houston, TX, US.
- 2017. Modified Tool Enabling Standard Transitions of Care Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center,. Conference. Modified Tool Enabling Standard Transitions of Care Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center,. Houston, TX, US.
- 2017. Poster Presentation: Modified Tool Enabling Standard Transitions of Care Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center. Conference. Poster Presentation: Modified Tool Enabling Standard Transitions of Care Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center. Houston, TX, US.
- 2015. Utilizing Electronic Technologies to Measure Pro Assessment Completion Time in Clinical Practice. Conference. Utilizing Electronic Technologies to Measure Pro Assessment Completion Time in Clinical Practice. Houston, TX, US.
- 2014. Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis. Conference. Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis. Houston, TX, US.
- 2014. Adjuvant Analgesics versus Opioids in the Management of Cancer Related Pain: Compared and Contrasted. Conference. Adjuvant Analgesics versus Opioids in the Management of Cancer Related Pain: Compared and Contrasted. Houston, TX, US.
- 2013. Adjuvant Analgesics in the Acute Inpatient Setting. Conference. Adjuvant Analgesics in the Acute Inpatient Setting. Houston, TX, US.
- 2013. Clinical Pearls. Conference. Clinical Pearls. Houston, TX, US.
Regional Presentations
- 2012. Caring for the Terminally Ill. Conference. Caring for the Terminally Ill, US.
- 2012. Clinical Pathology Conference (CPC). Conference. Clinical Pathology Conference (CPC), US.
National Presentations
- 2024. Session Chair: “E-Posters: Hemostasis + Neutropenia, Infection & Myelosuppression. Conference. MASCC 2024 Annual Meeting. Lille, FR.
- 2024. Cancer-Associated Thrombosis: Pioneering Strategies for Optimal Clinical Management of Thrombosis. Conference. MASCC 2024 Annual Meeting,. Lille, FR.
- 2023. “Cancer and the Immune System”: The use of medical animation to educate on immuno-oncology and immune-related adverse events. Conference. “Cancer and the Immune System”: The use of medical animation to educate on immuno-oncology and immune-related adverse events, US.
- 2022. Perceptions of expertise in Oncologic Hospital Medicine after completion of an Onco-Hospitalist Fellowship Program. Conference. Perceptions of expertise in Oncologic Hospital Medicine after completion of an Onco-Hospitalist Fellowship Program. Toronto, US.
- 2021. Essentials of Palliative Care in the Hospitalized Cancer Patient. Onco-Hospital Medicine Conference: A Multidisciplinary Approach to the Care of Hospitalized Patients with Cancer (virtual). Conference. Essentials of Palliative Care in the Hospitalized Cancer Patient. Onco-Hospital Medicine Conference: A Multidisciplinary Approach to the Care of Hospitalized Patients with Cancer (virtual), US.
- 2021. Onco-hospitalists and their increasing role in cancer patient care. Conference. Onco-hospitalists and their increasing role in cancer patient care, US.
- 2021. Perceptions of expertise in Oncologic Hospital Medicine after completion of an Onco-Hospitalist Fellowship Program. Conference. Perceptions of expertise in Oncologic Hospital Medicine after completion of an Onco-Hospitalist Fellowship Program, US.
- 2021. Educational Challenges and Opportunities at a Busy Nocturnal Onco-Hospitalist Admitting Service. Conference. Educational Challenges and Opportunities at a Busy Nocturnal Onco-Hospitalist Admitting Service, US.
- 2021. Educational Challenges and Opportunities at a Busy Nocturnal Onco-Hospitalist Admitting Service. The 2021 Innovations in Health Science Education Annual Conference(Virtual). Conference. Educational Challenges and Opportunities at a Busy Nocturnal Onco-Hospitalist Admitting Service. The 2021 Innovations in Health Science Education Annual Conference(Virtual), US.
- 2021. The Oncologic Hospital Medicine Fellowship Program: Making the Case. The 2021 Innovations in Health Science Education Annual Conference (virtual). Conference. The Oncologic Hospital Medicine Fellowship Program: Making the Case. The 2021 Innovations in Health Science Education Annual Conference (virtual), US.
- 2019. Cancer-associated Thrombotic Microangiopathy in a Patient with Metastatic Esophageal Adenocarcinoma. Conference. Cancer-associated Thrombotic Microangiopathy in a Patient with Metastatic Esophageal Adenocarcinoma, US.
- 2019. A Case of Nivolumab-Induced Myositis and Myasthenia Gravis. Conference. MASCC 2019. San Francisco, CA, US.
- 2019. Uncommon and Potentially Life-Threatening Complications from the Immune Checkpoint-Inhibitor Nivolumab at an Onco-Hospitalist Inpatient Service. Conference. Uncommon and Potentially Life-Threatening Complications from the Immune Checkpoint-Inhibitor Nivolumab at an Onco-Hospitalist Inpatient Service. San Francisco, CA, US.
- 2019. Onco-Hospitalists and their increasing role in cancer patient care. Conference. Onco-Hospitalists and their increasing role in cancer patient care. Houston, TX, US.
- 2017. Poster Presentation: A Wicked Tumor: Sinonasal Teratocarcinosarcoma. Conference. Poster Presentation: A Wicked Tumor: Sinonasal Teratocarcinosarcoma. Las Vegas, NV, US.
- 2016. Toxicities of the Anti-PD-1 Immune Checkpoint Antibody Nivolumab in the Acute Inpatient Setting. Conference. Toxicities of the Anti-PD-1 Immune Checkpoint Antibody Nivolumab in the Acute Inpatient Setting. San Francisco, CA, US.
- 2016. Utilizing Electronic Technologies To Measure Patient-reported Outcomes (PRO) Assessment Completion Time. Conference. Utilizing Electronic Technologies To Measure Patient-reported Outcomes (PRO) Assessment Completion Time. San Francisco, CA, US.
- 2015. Oncologic Inpatient Medical Emergencies. Conference. 3rd Conference on Medical Issues in Cancer Patients and Survivors. Houston, TX, US.
- 2014. Adjuvant Analgesics versus Opioids in the Management of Cancer-related Pain: Compared and Contrasted. Conference. Adjuvant Analgesics versus Opioids in the Management of Cancer-related Pain: Compared and Contrasted. Seoul.
International Presentations
- 2025. Prevention and management of bleeding complications in cancer patients: best practices and innovations. Invited. Oral Bleeding and Hemostasis in Cancer Patients, US.
- 2021. Utilization of social media at an international professional organization: The experience at the MASCC Hemostasis Study Group. Conference. Utilization of social media at an international professional organization: The experience at the MASCC Hemostasis Study Group, US.
- 2019. Oncologic Emergencies. Conference. Oncologic Emergencies. Osaka, Japan, US.
- 2018. The Oncologic Hospital Medicine Fellowship Program: Making the Case. Conference. The Oncologic Hospital Medicine Fellowship Program: Making the Case. Vienna, AT.
- 2018. A Challenging Case of New-Onset Paroxysmal Atrial Fibrillation with Rapid Ventricular Response Secondary to Autoimmune Thyroiditis After A Single Dose of Nivolumab-Ipilimumab. Conference. A Challenging Case of New-Onset Paroxysmal Atrial Fibrillation with Rapid Ventricular Response Secondary to Autoimmune Thyroiditis After A Single Dose of Nivolumab-Ipilimumab. Vienna, AT.
- 2018. The Oncologic Hospital Medicine Fellowship Program: Making the Case. Conference. The Oncologic Hospital Medicine Fellowship Program: Making the Case. Stockholm, SE.
- 2016. Oncologic Emergencies in the Patient with a Solid Tumor, E-Poster Presentation. Conference. Oncologic Emergencies in the Patient with a Solid Tumor, E-Poster Presentation. Adelaide, AU.
- 2016. Oncologic Emergencies in the Patient With a Solid Tumor. Conference. Oncologic Emergencies in the Patient With a Solid Tumor. Adelaide, AU.
- 2016. Toxicities of the Anti-PD-1 Immune Checkpoint Antibody Nivolumab in the Acute Inpatient Setting. Conference. Toxicities of the Anti-PD-1 Immune Checkpoint Antibody Nivolumab in the Acute Inpatient Setting. Adelaide, AU.
- 2016. Superior Vena Cava Syndrome: 3 cases, many lessons learned. Conference. Superior Vena Cava Syndrome: 3 cases, many lessons learned. Adelaide, AU.
- 2016. Oncologic Emergencies. Conference. Oral Presentation. Sao Paulo, BR.
- 2016. Superior Vena Cava Syndrome: 3 cases, Many Lessons Learned (Poster Presentation). Conference. Superior Vena Cava Syndrome: 3 cases, Many Lessons Learned (Poster Presentation). Sao Paulo, BR.
- 2015. Utilizing Electronic Technologies to Measure Pro Assessment Completion Time in Clinical Practice. Conference. Utilizing Electronic Technologies to Measure Pro Assessment Completion Time in Clinical Practice. Copenhagen, DK.
Formal Peers
- 2018. Handoffs and Physician Communication. Invited. Tyles, TX, US.
Selected Publications
Professional Educational Materials
- . Acute/Inpatient Clinical Care Pathway for the Initial Diagnosis and Management of Suspected Immune Checkpoint Inhibitor (ICI)-Mediated Pneumonitis. Instructional video (animation) on the diagnosis and management of ICI-mediated pneumonitis and the use of a clinical care pathway. MP4 format, 2022.
- . Cancer and the Immune System. Instructional video (animation) on Immuno-Oncology, , mp4 format, 2022.
Abstracts
- Balachandran Pillai A, Madewell J, Boving V, Brito-Dellan N, Manzano JG, Layman R, Mujtaba B, Goodman Y, Williams C. Enhancing gout diagnosis in cancer patients through dual-energy CT (DECT): A quality improvement initiative at MD Anderson Cancer Center. To be presented at MASCC 2024. Lille, France, 2024. e-Pub 2024.
- Manzano JG, Franco-Vega, M, Lu M, Sahar H, Leal-Alviarez D, Altay H, Ruiz-Ignazio J, Tomy S, Brito-Dellan N. Enhancing the Coordination of Care for Hospitalized Patients with Suspected Immune Checkpoint Inhibitor (ICI)-related Pneumonitis through the Development and Implementation of a Hospital-Based Clinical Care Pathway. Presented at The University of Texas Austin and MD Anderson Collaborative Research Summit, 2022. e-Pub 2022.
- Brito-Dellan N. Perceptions of expertise in Oncologic Hospital Medicine after completion of an Onco-Hospitalist Fellowship Program. 2021 Advances in Teaching and Learning Conference(Support Care Center (Suppl 1)):1-207, 2022. e-Pub 2022.
- Brito-Dellan N, Oo T, Rojas Hernandez C, Blum-Murphy M. Cancer-associated Thrombotic Microangiopathy in a Patient with Metastatic Esophageal Adenocarcinoma. Supportive Care in Cancer(27):S1-S302, 2019. e-Pub 2019.
Book Chapters
- Brites M, Brito-Dellan N. Apothecarius 1995 - 1996. In: Bromocriptina, 83-85, 1995.
Patient Reviews
CV information above last modified October 29, 2025